Valerie S LeBleu

10PUBLICATIONS
51CO-AUTHORS
Aerodynamics (excl. hypersonic aerodynamics)Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
Advancements in extracellular vesicle research.

|Sep 30, 2025
Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates.

Valerie S Kalluri, Brandon G Smaglo, Krishnan K Mahadevan

|Mar 17, 2025
KRAS G12D -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients.

Valerie S LeBleu, Brandon G Smaglo, Krishnan K Mahadevan

|Apr 01, 2024
Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome.

Valerie S LeBleu, Keizo Kanasaki, Sara Lovisa

|Apr 01, 2023
Identification of unique α4 chain structure and conserved antiangiogenic activity of α3NC1 type IV collagen in zebrafish.

Valerie S LeBleu, Jianli Dai, Susan Tsutakawa

|Feb 24, 2023
Oncogenic Kras G12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 + T cells dependent manner.

Krishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu

Pageof 2

Frequent Collaborators

7 joint publications

Raghu Kalluri

2 joint publications

Brandon G Smaglo

2 joint publications

Kathleen M McAndrews

2 joint publications

Krishnan K Mahadevan